EC Number   |
Reference  |
|---|
   3.4.23.20 | 2.8 A |
30587 |
| 3.4.23.20 | 6 A |
30593 |
| 3.4.23.20 | cocrystallized with inhibitor 1-L, space group C2, cell dimensions a 0 97.88 A, b = 46.64 A, c = 66.59 A |
649272 |
| 3.4.23.20 | crystal structure at: 1.8 A |
30600 |
| 3.4.23.20 | crystal structure in complex with inhibitor PPi3, monoclinic space group C2, a : 96.24 A, b : 46.47 A, c : 65.38 A, crystal structure in complex with inhibitor PPi4, monoclinic space group C2, a : 96.98 A, b : 46.65 A, c : 65.71 A |
649841 |
| 3.4.23.20 | crystal structure of native penicillopepsin and of its complex with a synthetic analogue of the inhibitor pepstatin at 1.8 A resolution |
30598 |
| 3.4.23.20 | crystallographic analysis of transition state mimics bound to penicillopepsin |
30601, 30602 |
| 3.4.23.20 | difluorostatine- and difluorostatone-containing peptides |
30601 |
| 3.4.23.20 | phosphorus-containing peptide analogues |
30602 |
| 3.4.23.20 | purified penicillopepsin-JT1, free or bound to difluorostatine- and difluorostatone-containing peptides, X-ray diffraction structure determination and analysis at 0.95-2.8 A resolution |
668813 |
